Joint Nordic Procurement – 2028 FGL, the Swedish Association for Generic Medicines and Biosimilars, welcomes the opportunity to comment on the proposed joint Nordic procurement.
Joint Nordic Procurement – 2028 FGL, the Swedish Association for Generic Medicines and Biosimilars, welcomes the opportunity to comment on the proposed joint Nordic procurement. FGL’s starting point is that regional procurement is preferable to national procurement. We oppose a general move towards centralised Nordic procurement. Centralisation risks excluding smaller and newly established suppliers [...]